| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/29/2004 | US20040147725 for cancer treatment by inducing apoptosis; monoclonal antibodies; genetic engineering; kits |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147721 Antigens and vectors for vaccination |
| 07/29/2004 | US20040147609 Liquid drug preparations |
| 07/29/2004 | US20040147474 For use as vaccines against bacterial infections, diagnosis, prophylactic and therapeutic uses. |
| 07/29/2004 | US20040147473 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147467 For producing an immune response in fish |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147440 Compositions comprising cell-impermeant duramycin derivatives |
| 07/29/2004 | US20040147435 Compositions and methods for importing biologically active molecules into cells and for treating inflammation |
| 07/29/2004 | US20040147044 Antigens |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146991 Identifying modulator of activation inducible lymphocyte immunomodulatory molecule (AILIM) for use in suppressing, preventing and/or treating inflammatory, autoimmune and allergic disorders |
| 07/29/2004 | US20040146990 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146970 Proteins associated with cell growth, differentiation, and death |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146954 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 07/29/2004 | US20040146940 Cripto blocking antibodies and uses thereof |
| 07/29/2004 | US20040146933 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/29/2004 | US20040146930 for diagnosing susceptibility to a pathological condition based on the presence or absence of mutation; drug screening; genetic engineering |
| 07/29/2004 | US20040146925 for diagnosis and targeted drug delivery for blood cancer and monitoring protein expression or activity of white blood cells in vitro |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146860 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 07/29/2004 | US20040146859 Nucleotide sequences coding hemorrhagic viral protein for use in detection and treatment of viral diseases; viricides; genetic vaccines |
| 07/29/2004 | US20040146854 Attenuated forms of bovine viral diarrhea virus |
| 07/29/2004 | US20040146591 Solvent extraction, mixing with aqueous solution; drying; sterilization; drugs, food; aging resistance, cognition activators , brain disorders; incontinence; Alzheimer's disease, autism, Parkinson's disease, antiarthritic agents |
| 07/29/2004 | US20040146549 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 07/29/2004 | US20040146534 Vaccine for transcutaneous immunization |
| 07/29/2004 | US20040146533 Useful for vaccinating |
| 07/29/2004 | US20040146532 Agents and methods for treating pain |
| 07/29/2004 | US20040146531 Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cells |
| 07/29/2004 | US20040146530 Avian vaccine effective against infectious bursal disease virus |
| 07/29/2004 | US20040146529 HBV/HCV virus-like particle |
| 07/29/2004 | US20040146528 MVA expressing modified HIV envelope, gag, and pol genes |
| 07/29/2004 | US20040146527 Pertussis toxin gene: cloning and expression of protective antigen |
| 07/29/2004 | US20040146524 Immunogen for a vaccine or inoculum |
| 07/29/2004 | US20040146522 For therapy of individual exposed to or infected with HIV-1 |
| 07/29/2004 | US20040146521 Prevention and treatment of synucleinopathic disease |
| 07/29/2004 | US20040146520 Materials and methods relating to immune suppression |
| 07/29/2004 | US20040146519 For use in vaccines, prophylaxis and therapy of cancer |
| 07/29/2004 | US20040146517 For therapy of illnesses of the cardio-vascular system |
| 07/29/2004 | US20040146515 Chemically programmable immunity |
| 07/29/2004 | US20040146513 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 07/29/2004 | US20040146512 Administering monoclonal antibodies to treat Down syndrome |
| 07/29/2004 | US20040146511 Administering an anti-coagulation factor monoclonal antibody having self-limiting neutralizing activity with plasminogen activator |
| 07/29/2004 | US20040146509 Methods for improvement of lung function using TGF-beta inhibitors |
| 07/29/2004 | US20040146508 Use of cd25 binding molecules in steroid-resistant patients |
| 07/29/2004 | US20040146506 Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies |
| 07/29/2004 | US20040146505 Polypeptide comprising portion with part of human fc fragment which binds to CD64 antigen, and portion comprising heterologous T cell epitopes; antitumor and anticarcinogenic agents |
| 07/29/2004 | US20040146504 Anti-IgE vaccines |
| 07/29/2004 | US20040146503 Methods and compositions for inducing stable immune tolerance |
| 07/29/2004 | US20040146502 Use of organic compounds |
| 07/29/2004 | US20040146486 One unit engineered to constitutively express co-stimulator and another can be engineered to express single, fusion or multiple antigens derived from disease causing pathogen |
| 07/29/2004 | US20040146485 Vaccines including as an adjuvant type 1 ifn and process related thereto |
| 07/29/2004 | US20040146484 Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant |
| 07/29/2004 | US20040146459 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 07/29/2004 | CA2513813A1 Novel method for isolating endotoxins |
| 07/29/2004 | CA2513701A1 Dimerized peptide |
| 07/29/2004 | CA2513279A1 Pharmaceutical aerosol composition |
| 07/29/2004 | CA2513072A1 Cellular delivery and activation polypeptide-nucleic acid complexes |
| 07/29/2004 | CA2512974A1 Soluble fc.gamma.r fusion proteins and methods of use thereof |
| 07/29/2004 | CA2512812A1 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 07/29/2004 | CA2512672A1 Methods of treating lung diseases |
| 07/29/2004 | CA2512545A1 Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf) |
| 07/29/2004 | CA2511659A1 Methods for reducing mortality associated with acute myocardial infarction |
| 07/28/2004 | EP1441033A2 Eukaryotic gene expression cassette based on Herpes simplex virus |
| 07/28/2004 | EP1440169A1 Methods and compositions for the treatment and diagnosis of pain disorders using 57749 |
| 07/28/2004 | EP1440166A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
| 07/28/2004 | EP1440165A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 07/28/2004 | EP1440163A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566 |
| 07/28/2004 | EP1440156A2 Antigens and vectors for vaccination |
| 07/28/2004 | EP1440149A2 Infectious and attenuated bovine viral diarrhea virus clones; methods for their production and use |
| 07/28/2004 | EP1440114A1 Material consisting of at least a biodegradable polymer and cyclodextrins |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440090A2 A synthetic chimeric fusion protein with immuno-therapeutic uses |
| 07/28/2004 | EP1440087A2 Mycobacterial genes down-regulated during latency |
| 07/28/2004 | EP1440086A1 Infectious salmon anaemia virus vaccine |
| 07/28/2004 | EP1439864A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1439862A2 Methods and compositions for the treatment and diagnosis of pain disorders using 9805 |
| 07/28/2004 | EP1439856A1 Recombinant rabies vaccine and methods of preparation and use |
| 07/28/2004 | EP1175445B1 Specific antibodies and antibody fragments for tgfbeta1 |
| 07/28/2004 | EP0983286B1 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| 07/28/2004 | EP0938335B1 In ovo vaccination against newcastle disease |
| 07/28/2004 | EP0920509B1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 07/28/2004 | EP0839911B1 Method for identifying attenuated varicella virus oka strain or a strain derived therefrom |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516735A Method to generate non-virulent microorganism from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
| 07/28/2004 | CN1516595A Patch for transcutaneous immunization |
| 07/28/2004 | CN1515319A Induction of cytotoxic T lymphocyte response |
| 07/28/2004 | CN1515253A New application of 1,3-propylene glycol derivative |
| 07/28/2004 | CN1515245A Vaccine containing saponin and sterol |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159453C Methods for identifying pathogenic markers in sample o normal cells |
| 07/28/2004 | CN1159441C USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 07/28/2004 | CN1159338C LHRH tandem repeat peptide and vaccine and immunogenic composition |
| 07/28/2004 | CN1159333C Trichina antigen gene Ts 87 and use thereof |
| 07/28/2004 | CN1159330C Anticancer presursor compound containing anthracycle cytotoxins, its preparing process and itd medicine |